ArticleHaematologica2024

Brentuximab vedotin with chemotherapy in adolescents and young adults with stage III or IV classical Hodgkin lymphoma in ECHELON-1.

Howland E Crosswell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.